Investors Watch List: Dicerna Pharmaceuticals (NASDAQ:DRNA), Agilent Technologies Inc. (NYSE:A), Take-Two Interactive Software (NASDAQ:TTWO), Vertex Pharmaceuticals (NASDAQ:VRTX), South Jersey Industries (NYSE:SJI)

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) in last trading activity advanced 3.84% to close at $20.27. Company weekly performance is -10.51% while its quarterly performance stands at -5.98%. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) is -25.83% away from its 52 week high. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) announced the commencement of a proposed underwritten public offering of 2,750,000 shares of common stock. Dicerna also intends to grant the underwriters a 30-day option to purchase up to an additional 412,500 shares of common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

On Monday shares of Agilent Technologies Inc. (NYSE:A) closed at $42.63. Company’s sales growth for last 5 years was 9.30% and EPS growth for next 5 years is recorded as 12.75%. Agilent Technologies Inc. (NYSE:A) reported net income for the second quarter of $83 million or $0.25 per share, compared to $139 million or $0.41 per share for the year-ago quarter.

Take-Two Interactive Software Inc. (NASDAQ:TTWO) in last trading activity decreased -1.98% to close at $24.20. Company weekly performance is -3.62% while its quarterly performance stands at -13.97%. Take-Two Interactive Software Inc. (NASDAQ:TTWO) is -21.43% away from its 52 week high. Take-Two Interactive Software Inc. (NASDAQ:TTWO), reported fiscal fourth-quarter earnings that beat analysts’ estimates on the strength of its shoot ’em up titles. The company forecast sales of $325 million to $350 million and earnings per share of 25 cents to 35 cents for its fiscal first quarter that ends in June. Adjusted revenue in the fourth quarter rose 83 percent to $427.7 million, trailing the $462.3 million average of analysts’ predictions.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has 0.60% insider ownership while its institutional ownership stands at 98.80%. In last trading activity company’s stock closed at $127.31. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced that the New England Journal of Medicine (NEJM) published data from the two Phase 3 studies of ORKAMBITM (lumacaftor/ivacaftor), an investigational medicine designed to treat the underlying cause of cystic fibrosis (CF) in people ages 12 and older with two copies of the F508del mutation, the most common form of the disease.

On last trading day South Jersey Industries, Inc. (NYSE:SJI) advanced 0.37% to close at $26.81. Its volatility for the week is 1.60% while volatility for the month is 1.99%. SJI’s sales growth for past 5 years was 1.00% and its EPS growth for past 5 years was -5.70%. South Jersey Industries, Inc. (NYSE:SJI) monthly performance is 2.09%. South Jersey Industries Inc. (NYSE:SJI) on May 08, reported first-quarter earnings of $53.6 million. The Folsom, New Jersey-based company said it had net income of 79 cents per share. Earnings, adjusted for non-recurring costs and to account for discontinued operations, came to 86 cents per share.

Leave a Reply

Your email address will not be published. Required fields are marked *